alpha,beta-methyleneadenosine 5'-triphosphate has been researched along with cardiovascular agents in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ralevic, V | 1 |
| Ikomi, F; Kousai, A; Mizuno, R; Ohhashi, T | 1 |
2 other study(ies) available for alpha,beta-methyleneadenosine 5'-triphosphate and cardiovascular agents
| Article | Year |
|---|---|
Mechanism of prolonged vasorelaxation to ATP in the rat isolated mesenteric arterial bed.
Topics: Adenosine Triphosphate; Animals; Capsaicin; Cardiotonic Agents; Cardiovascular Agents; Charybdotoxin; Drug Interactions; Electric Stimulation; Endothelium, Vascular; Glyburide; In Vitro Techniques; Indomethacin; Isotonic Solutions; Male; Mesenteric Arteries; Neurons, Afferent; Ouabain; Pyridoxal Phosphate; Rats; Rats, Wistar; Suramin; Tetraethylammonium; Theophylline; Vasodilation | 2001 |
ATP inhibits pump activity of lymph vessels via adenosine A1 receptor-mediated involvement of NO- and ATP-sensitive K+ channels.
Topics: Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Antineoplastic Agents; Arginine; Cardiovascular Agents; Endothelium; Enzyme Inhibitors; Glyburide; Indomethacin; Lymphatic System; Male; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nitric Oxide; Potassium Channels; Rats; Rats, Wistar; Receptor, Adenosine A1; Suramin; Xanthines | 2004 |